Armata Pharmaceuticals (ARMP) Current Deferred Revenue (2013 - 2018)
Armata Pharmaceuticals (ARMP) posted Current Deferred Revenue of $335000.0 for Q4 2018, up 1575.0% sequentially from $20000.0 in Q3 2017.
Armata Pharmaceuticals (ARMP) Current Deferred Revenue (2013 - 2018) Analysis & Trends
Armata Pharmaceuticals has reported Current Deferred Revenue for 6 years, with the latest figure at $335000.0 in Q4 2018.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $335000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $335000.0 (changed N/A YoY) and the FY2018 annual result came in at $335000.0, changed N/A from the prior year.
- Current Deferred Revenue improved to $335000.0 in Q4 2018 per ARMP's latest filing, from $20000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $350000.0 in Q2 2015 and troughed at $18000.0 in Q3 2016.
- A 5-year average of $177666.7 and a median of $142000.0 in 2015 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2016 and 2017: Current Deferred Revenue slumped 92.71% in 2016, then surged 34.88% in 2017.
- Over 5 years, Current Deferred Revenue stood at $244000.0 in 2014, then climbed by 0.41% to $245000.0 in 2015, then tumbled by 92.65% to $18000.0 in 2016, then rose by 11.11% to $20000.0 in 2017, then soared by 1575.0% to $335000.0 in 2018.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $335000.0, $20000.0, and $58000.0 for Q4 2018, Q3 2017, and Q2 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 335,000.00 |
| Sep 30, 2017 | 20,000.00 |
| Jun 30, 2017 | 58,000.00 |
| Mar 31, 2017 | 86,000.00 |
| Sep 30, 2016 | 18,000.00 |
| Jun 30, 2016 | 43,000.00 |
| Mar 31, 2016 | 142,000.00 |
| Dec 31, 2015 | 245,000.00 |
| Sep 30, 2015 | 247,000.00 |
| Jun 30, 2015 | 350,000.00 |
| Mar 31, 2015 | 142,000.00 |
| Dec 31, 2014 | 244,000.00 |
| Sep 30, 2014 | 246,000.00 |
| Jun 30, 2014 | 349,000.00 |
| Mar 31, 2014 | 140,000.00 |
| Dec 31, 2013 | 244,000.00 |